Abbott’s second-quarter earnings showed a mixed bag with pandemic disruptions on the medical device side of the business, and sales of COVID-19 tests driving growth for the diagnostic side.
https://i0.wp.com/mtgelectronics.com/wp-content/uploads/2020/07/shutterstock_105421997.jpg?fit=1000%2C667&ssl=1 667 1000 admin https://mtgelectronics.com/wp-content/uploads/2021/03/MTG-logo-for-site-300x100-1.png admin2020-07-23 08:40:452022-06-21 15:53:15Abbott’s COVID-19 tests did the heavy lifting in Q2
You might also like
- Enics Merges with GPV to Create a European Electronics GiantJune 23, 2022 - 1:11 pm
- Panthronics announces integrated listener for NFC wireless charging cuts board footprintJune 22, 2022 - 9:00 am
- EOL: The Chip Shortage You Don’t See ComingJune 21, 2022 - 3:24 pm
- Investing in Harsh Environment Solutions for Oil & Gas ExplorationJune 21, 2022 - 2:25 pm